[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100339799":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":19,"locations":25,"responsibleParty":42,"collaborators":18,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":18,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":18,"enrollmentInfo":54,"targetDuration":18,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":18,"overallStatus":28,"whyStopped":18,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Vanderbilt University Medical Center","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Nasal Nitric Oxide testing and collection of clinical data","Participants will have nNO testing is indicated. All participants in this study have some basic clinical data collected at time of enrollment. Participants with a confirmed diagnosis of PCD or in those participants with a working diagnosis of PCD in which ongoing nNO testing is performed have prospective data collection. Some participants have a confirmed diagnosis of PCD by genetics or ciliary biopsy at time of study entry and thus do not need nNO testing, but are followed prospectively with collection of basic clinical data",[12],"Other: nNO testing",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":18},"nNO testing","Collection of already performed clinical data and nNO testing",[9],null,[20],{"name":21,"role":22,"phone":23,"phoneExt":18,"email":24},"Michael O'Connor, MD","CONTACT","615.343.7617","michael.g.oconnor@vumc.org",[26],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Vanderbilt Children's hospital","RECRUITING","Nashville","Tennessee","37232","United States","US",{"type":35,"coordinates":36},"Point",[37,38],-86.78444,36.16589,{"lat":38,"lon":37},[41],{"name":21,"role":22,"phone":18,"phoneExt":18,"email":18},{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Michael O'Connor","Assistant Professor","100339799","utility-of-pcd-diagnostics-to-improve-clinical-care-100339799",false,"NCT03704207","Utility of PCD Diagnostics to Improve Clinical Care","Inclusion Criteria:\n\n* Referred to center for PCD diagnosis considerations\n* Ability to perform study procedures\n* Age greater than 2 years of age\n\nExclusion Criteria:\n\n* Age less than 2 years of age Inability to perform informed consent","ALL","1 Year",{"count":55,"type":56},200,"ESTIMATED","INTERVENTIONAL",[59],"NA","This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.",[62],"Primary Ciliary Dyskinesia","2025-06-28",{"date":65,"type":66},"2025-07-01","ACTUAL",{"date":68,"type":66},"2017-06-01",{"date":70,"type":56},"2028-06-01",{"name":5,"class":6},1]